MeVis Medical Solutions AG
AI solutions promoting early lung cancer detection and treatment.
Company Overview
MeVis aims to contribute to the early detection and diagnostics of cancer, thus facilitating an early and tailored treatment of the disease. In order to meet this challenge, MeVis develops innovative software for the analysis and processing of image data.
From the beginning of a product idea, via the development of an application and their integration into customer specific platforms to the point of effective quality assurance, MeVis accompany their industrial customers.
Their clinical focus is the image-based early detection and diagnostics of epidemiologically significant conditions such as breast, lung, liver, prostate and intestinal cancer as well as neurological diseases. Furthermore, they provide technical visualizations for professional education, publication, presentation, and research.
Modalities
Subspecialities
Applications available
Veolity™ LungCAD
Computer-aided detection (CAD) for solid pulmonary nodules for chest CT scans in lung cancer diagnostics.
CE
FDA
CT
Pulmonology
Oncology
To find out more about MeVis’s solutions, or the 100+ other applications on the Blackford Platform, book a discovery call with our team.
Book a meeting
We’d welcome the opportunity to learn more about your AI needs and to explain how partnering with Blackford can drive efficiency and provide ongoing value.
Book a Meeting